Canada Life’s Albireo Pharma Inc ALBO Stock Holding History

Canada Life’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,031	Closed	-$22K	–	2342
2022 Q4	$22K	Hold	1,031	–	–	﹤0.01%	2242
2022 Q3	$20K	Hold	1,031	–	–	﹤0.01%	2267
2022 Q2	$20K	Hold	1,031	–	–	﹤0.01%	2271
2022 Q1	$33K	Hold	1,031	–	–	﹤0.01%	2260
2021 Q4	$24K	Hold	1,031	–	–	﹤0.01%	2343
2021 Q3	$32K	Hold	1,031	–	–	﹤0.01%	2347
2021 Q2	$36K	Hold	1,031	–	–	﹤0.01%	2358
2021 Q1	$36K	Hold	1,031	–	–	﹤0.01%	2398
2020 Q4	$39K	Buy	+1,031	New	+$37.5K	﹤0.01%	2373

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Canada Life's ALBO Position: Q1 2023 in Review

Canada Life sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,031 shares — an estimated $22K sold.

Canada Life first reported a position in ALBO in Q4 2020 and held it in 9 quarters. The position peaked at $39K in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Canada Life reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Canada Life sold 1,031 Albireo Pharma Inc shares in Q1 2023, an estimated $22K.
Canada Life first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 9 quarters.
Canada Life's Albireo Pharma Inc position peaked at $39K in Q4 2020.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.